Angelo Ceci
Biberach An Der Riss, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain.
Journal: Bioanalysis
Published: August 16, 2016
Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Journal: Neuroscience letters
Published: December 29, 2015
Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase.
Journal: Brain, behavior, and immunity
Published: July 24, 2015
CD40-TNF activation in mice induces extended sickness behavior syndrome co-incident with but not dependent on activation of the kynurenine pathway.
Journal: Brain, behavior, and immunity
Published: April 18, 2015
Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds.
Journal: Bioorganic & medicinal chemistry letters
Published: October 07, 2014
Selective CB2 receptor agonists. Part 3: the optimization of a piperidine-based series that demonstrated efficacy in an in vivo neuropathic pain model.
Journal: Bioorganic & medicinal chemistry letters
Published: October 07, 2014
Tramadol reduces anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats.
Journal: Pharmacology, biochemistry, and behavior
Published: October 12, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026